Nymox Pharmaceutical (PK) 주식 가격. NYMXF - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
USOTC
Nymox Pharmaceutical Corp (PK) (NYMXF) 시세

Nymox Pharmaceutical Corp (PK) (NYMXF)

0.10

0.0249

(33.16%)

마감 03 12월 6:00AM

개인 투자자를 위한 전문가급 도구.

가격

0.10

매수가

0.09

매도가

0.15

거래량

35,750

0.07 일간 변동폭 0.10

0.0001 52주 범위 1.40

market_cap

전일 종가

0.0751

개장가

0.08

최근 거래 시간

마지막 거래 시간

재정 규모

US$ 3,206

VWAP

0.08968

평균 볼륨(3m)

16,530

발행 주식

93,540,140

배당수익률

-

주가수익률

-2.12

주당순이익(EPS)

-0.09

매출

-

순이익

-8.84M

섹터

Chemicals & Chem Preps, Nec

산업

Chemicals & Chem Preps, Nec

웹사이트

www.nymox.com

본부

Nassau, Bhs

설립됨

-

Nymox Pharmaceutical Corp (PK) is listed in the Chemicals & Chem Preps sector of the OTC 시장 with ticker NYMXF. The last closing price for Nymox Pharmaceutical (PK) was US$0.08. Over the last year, Nymox Pharmaceutical (PK) shares have traded in a share price range of US$ 0.0001 to US$ 1.40.

Nymox Pharmaceutical (PK) currently has 93,540,140 shares in issue. The market capitalisation of Nymox Pharmaceutical (PK) is US$7.02 million. Nymox Pharmaceutical (PK) has a price to earnings ratio (PE ratio) of -2.12.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0.1	0.15	0.05	25298	0.12826331	CS
4	0.0595	146.913580247	0.0405	0.16	0.03	27880	0.08906197	CS
12	0.03	42.8571428571	0.07	0.28	0.0011	16530	0.11174521	CS
26	-0.15	-60	0.25	1.4	0.0001	16722	0.11938896	CS
52	-0.83	-89.247311828	0.93	1.4	0.0001	19340	0.30514759	CS
156	-0.02	-16.6666666667	0.12	1.4	0.0001	41060	0.6696032	CS
260	-0.02	-16.6666666667	0.12	1.4	0.0001	41060	0.6696032	CS

가장 활성
% 상승자
% 패자

기호	가격	볼륨
KBNTKubient Inc (CE)	US$ 0.0003 (29,900.00%)	400
YAYOYayYo Inc (CE)	US$ 0.0002 (19,900.00%)	15.71k
NHIQNantHealth Inc (CE)	US$ 0.25 (12,400.00%)	1.12k
ARDSAridis Pharmaceuticals Inc (CE)	US$ 0.0001 (9,900.00%)	33.37k
NSTBNorthern Star Investment Corporation II (CE)	US$ 0.01 (9,900.00%)	300
CLVRClever Leaves Holdings Inc (CE)	US$ 0.0002 (-99.98%)	676
CITLFCritical Infrastructure Technologies Ltd (PK)	US$ 0.0001 (-99.96%)	500
RQHTFReliq Health Technologies Inc (CE)	US$ 0.000001 (-99.91%)	100
EORBFOrbite Technologies Inc (CE)	US$ 0.000001 (-99.69%)	95.8k
ANTHAnthera Pharmaceuticals Inc (CE)	US$ 0.000001 (-99.50%)	428
RDARRaadr Inc (PK)	US$ 0.0011 (29.41%)	407.34M
CMGRClubhouse Media Group Inc (PK)	US$ 0.0001 (0.00%)	304.71M
DPUIDiscount Print USA Inc (PK)	US$ 0.0003 (50.00%)	187.09M
HMBLHUMBL Inc (PK)	US$ 0.0003 (50.00%)	105.08M
DRNGDrone Guarder Inc (PK)	US$ 0.00025 (25.00%)	88.96M

Renee

Renee 1 년 전

NYMX changed to NYMXF. Delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions

Triple nickle

Triple nickle 1 년 전

Spicknspan

Spicknspan 2 년 전

A one time injectable treatment for an enlarged prostate would have a huge market. Bought a few here so I know I will keep an eye on the news.

Suds Mackenzie

Suds Mackenzie 3 년 전

NDA not coming soon?

Suds Mackenzie

Suds Mackenzie 3 년 전

NDA Coming soon?

Suds Mackenzie

Suds Mackenzie 3 년 전

Up today on NO news?

Suds Mackenzie

Suds Mackenzie 3 년 전

Delays and more delays and now more dilution. $.50 coming soon.

Suds Mackenzie

Suds Mackenzie 3 년 전

Will NYMX file NDA by 9/15/21?

lytnup

lytnup 3 년 전

Less than a month away.

Nymox Announces Date for Fexapotide Filing
NEWS RELEASE
HASBROUCK HEIGHTS, NJ (May 6, 2021) Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it will be filing for marketing approval of Fexapotide Triflutate for BPH before the end of the summer, on or before 15 September 2021.
CEO Dr Paul Averback said, "The Company will file on or before September 15. We hope but cannot be certain that the date may be before September. Company management will communicate updates where appropriate."

https://nymox.com/files/download/45b2b195922068b

Suds Mackenzie

Suds Mackenzie 3 년 전

2ND QUARTER RESULTS DISSAPOINTING AS USUAL. STILL NO UPDATES ON NDA.

Suds Mackenzie

Suds Mackenzie 3 년 전

NDA appication coming soon? I have my doubts.

Suds Mackenzie

Suds Mackenzie 3 년 전

Suds Mackenzie

Suds Mackenzie 4 년 전

Director - James G Robinson just picked up 38,000 shares. This was his first purchase in over a 1 1/2 years and he now owns 3,550,550 shares. He has done this many times and usually buys when it drops to around $2 or less. He is 85 years old now and God Bless he lives long enough to see this drug get FDA approval and come to market.

stillchillin

stillchillin 4 년 전

Who is buying today?? Is it GR loading up in front of good news? He has a boat load and has been holding for a while

wesley_

wesley_ 4 년 전

$2.48 picked some up

Suds Mackenzie

Suds Mackenzie 4 년 전

Good news or bad? The clock is ticking!

Suds Mackenzie

Suds Mackenzie 4 년 전

Going down down down down down!

Suds Mackenzie

Suds Mackenzie 4 년 전

ANOTHER NICE DAY!

Suds Mackenzie

Suds Mackenzie 4 년 전

BIG NEWS COMING IN Q1.

Suds Mackenzie

Suds Mackenzie 4 년 전

Suds Mackenzie

Suds Mackenzie 4 년 전

NDA - Ist quarter 2021, could it finally happen?

Suds Mackenzie

Suds Mackenzie 4 년 전

Big news coming soon?

Suds Mackenzie

Suds Mackenzie 4 년 전

The year is almost over and still no significant news!

Suds Mackenzie

Suds Mackenzie 4 년 전

What is taking so long???

Suds Mackenzie

Suds Mackenzie 4 년 전

NDA NDA NDA NDA ?

Suds Mackenzie

Suds Mackenzie 4 년 전

Even more dilution???

Suds Mackenzie

Suds Mackenzie 4 년 전

NEWS TODAY. GOOD, BAD OR SAME OLD SAME OLD.

Suds Mackenzie

Suds Mackenzie 4 년 전

More dilution - $12,000,000 stock offering.

https://ih.advfn.com/stock-market/NASDAQ/nymox-pharmaceutical-NYMX/stock-news/82880626/prospectus-filed-pursuant-to-rule-424b5-424b5

Suds Mackenzie

Suds Mackenzie 4 년 전

Starting to turn Bearish on this.

Suds Mackenzie

Suds Mackenzie 4 년 전

Will NYMX ever succeed?

Suds Mackenzie

Suds Mackenzie 4 년 전

NDA ?? I will believe it when I see it.

Suds Mackenzie

Suds Mackenzie 4 년 전

Dog and pony show continues.

Suds Mackenzie

Suds Mackenzie 4 년 전

Tick Tick Tick....

Suds Mackenzie

Suds Mackenzie 5 년 전

Hopefully good news coming soon.

Suds Mackenzie

Suds Mackenzie 5 년 전

What's the holdup?

Suds Mackenzie

Suds Mackenzie 5 년 전

$12,000,000. STOCK OFFERING.

https://ih.advfn.com/stock-market/NASDAQ/nymox-pharmaceutical-NYMX/stock-news/82306706/securities-registration-foreign-private-issuer-f-3

Suds Mackenzie

Suds Mackenzie 5 년 전

Even the Coronavirus can't keep NYMX down.

Suds Mackenzie

Suds Mackenzie 5 년 전

Hope this drops under $2, I will stock up.

Suds Mackenzie

Suds Mackenzie 5 년 전

Lots of news lately. Hoping for the NDA soon.

tayronachan

tayronachan 5 년 전

But will they have anything to offer in helping stop the new corona virus, or helping the victims?
Any of this?..........."The Company has research interests in protein markers, subcellular pathology, cell death, cell proliferation, clinical models, genetic expression, morphology, and drug screening design, assays, and development. Nymox maintains an active interest in scientific collaborations and has a lengthy history of working together with prominent researchers around the world."

zumantu

zumantu 5 년 전

Suds Mackenzie

Suds Mackenzie 5 년 전

Tick, tick, tick, tick.

Suds Mackenzie

Suds Mackenzie 5 년 전

Nymox Announces New Peer Review Article on Fexapotide Pharmaco-Ablation Experimental Studies Published in Research and Report...

yankees18

yankees18 5 년 전

Suds Mackenzie

Suds Mackenzie 5 년 전

Happy New Year for NYMX.

Suds Mackenzie

Suds Mackenzie 5 년 전

Fraud, Failure or Look for NDA in 2020

Suds Mackenzie

Suds Mackenzie 5 년 전

As at November 15, 2019, 69,968,706 common shares without par value of the Corporation were outstanding.

Suds Mackenzie

Suds Mackenzie 5 년 전

RESULTS FORTHCOMING.

Suds Mackenzie

Suds Mackenzie 5 년 전

2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020

zumantu

zumantu 5 년 전

Did I miss the big news?

Nymox Pharmaceutical (PK)

Elevation Gold Mining

AFG 2024 1 Trust in Resp...

Ausnet Services Holdings...

Buddy Technologies

Great Northern Minerals

Ironbark Capital

Thomson Resources

International Finance

Atlantica Sustainable In...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관